|
1
|
Chandran SS, Somerville RPT, Yang JC,
Sherry RM, Klebanoff CA, Goff SL, Wunderlich JR, Danforth DN, Zlott
D, Paria BC, et al: Treatment of metastatic uveal melanoma with
adoptive transfer of tumour-infiltrating lymphocytes: A
single-centre, two-stage, single-arm, phase 2 study. Lancet Oncol.
18:792–802. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Robertson AG, Shih J, Yau C, Gibb EA, Oba
J, Mungall KL, Hess JM, Uzunangelov V, Walter V, Danilova L, et al:
Integrative analysis identifies four molecular and clinical subsets
in uveal melanoma. Cancer Cell. 32:204–220.e15. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Field MG, Durante MA, Anbunathan H, Cai
LZ, Decatur CL, Bowcock AM, Kurtenbach S and Harbour JW: Punctuated
evolution of canonical genomic aberrations in uveal melanoma. Nat
Commun. 9:1162018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lane AM, Kim IK and Gragoudas ES: Survival
rates in patients after treatment for metastasis from uveal
melanoma. JAMA Ophthalmol. 136:981–986. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yoo JH, Shi DS, Grossmann AH, Sorensen LK,
Tong Z, Mleynek TM, Rogers A, Zhu W, Richards JR, Winter JM, et al:
ARF6 is an actionable node that orchestrates oncogenic GNAQ
signaling in uveal melanoma. Cancer Cell. 29:889–904. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Batista PJ and Chang HY: Long noncoding
RNAs: Cellular address codes in development and disease. Cell.
152:1298–1307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu Y, Zhang R, Qiu F, Li K, Zhou Y, Shang
D and Xu Y: Construction of a lncRNA-PCG bipartite network and
identification of cancer-related lncRNAs: A case study in prostate
cancer. Mol Biosyst. 11:384–393. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ye B, Liu B, Yang L, Zhu X, Zhang D, Wu W,
Zhu P, Wang Y, Wang S, Xia P, et al: LncKdm2b controls self-renewal
of embryonic stem cells via activating expression of transcription
factor Zbtb3. EMBO J. 37:e971742018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang L, Meng X, Zhu XW, Yang DC, Chen R,
Jiang Y and Xu T: Long non-coding RNAs in Oral squamous cell
carcinoma: Biologic function, mechanisms and clinical implications.
Mol Cancer. 18:1022019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Martens-Uzunova ES, Bottcher R, Croce CM,
Jenster G, Visakorpi T and Calin GA: Long noncoding RNA in
prostate, bladder, and kidney cancer. Eur Urol. 65:1140–1151. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Parasramka MA, Maji S, Matsuda A, Yan IK
and Patel T: Long non-coding RNAs as novel targets for therapy in
hepatocellular carcinoma. Pharmacol Ther. 161:67–78. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang G, Zhang ZJ, Jian WG, Liu PH, Xue W,
Wang TD, Meng YY, Yuan C, Li HM, Yu YP, et al: Novel long noncoding
RNA OTUD6B-AS1 indicates poor prognosis and inhibits clear cell
renal cell carcinoma proliferation via the Wnt/β-catenin signaling
pathway. Mol Cancer. 18:152019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Murugan AK, Munirajan AK and Alzahrani AS:
Long noncoding RNAs: Emerging players in thyroid cancer
pathogenesis. Endocr Relat Cancer. 25:R59–R82. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huang JL, Zheng L, Hu YW and Wang Q:
Characteristics of long non-coding RNA and its relation to
hepatocellular carcinoma. Carcinogenesis. 35:507–514. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang FW, Cao CH, Han K, Zhao YX, Cai MY,
Xiang ZC, Zhang JX, Chen JW, Zhong LP, Huang Y, et al:
APC-activated long noncoding RNA inhibits colorectal carcinoma
pathogenesis through reduction of exosome production. J Clin
Invest. 129:727–743. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Noh JH and Gorospe M: AKTions by
cytoplasmic lncRNA CASC9 promote hepatocellular carcinoma survival.
Hepatology. 68:1675–1677. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zheng X, Tang H, Zhao X, Sun Y, Jiang Y
and Liu Y: Long non-coding RNA FTH1P3 facilitates uveal melanoma
cell growth and invasion through miR-224-5p. PLoS One.
12:e01847462017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lu Q, Zhao N, Zha G, Wang H, Tong Q and
Xin S: LncRNA HOXA11-AS exerts oncogenic functions by repressing
p21 and miR-124 in uveal melanoma. DNA Cell Biol. 36:837–844. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lu L, Yu X, Zhang L, Ding X, Pan H, Wen X,
Xu S, Xing Y, Fan J, Ge S, et al: The long non-coding RNA RHPN1-AS1
promotes uveal melanoma progression. Int J Mol Sci. 18(pii):
E2262017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li Y, Zeng C, Hu J, Pan Y, Shan Y, Liu B
and Jia L: Long non-coding RNA-SNHG7 acts as a target of miR-34a to
increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in
colorectal cancer progression. J Hematol Oncol. 11:892018.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ota T, Suzuki Y, Nishikawa T, Otsuki T,
Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, et al:
Complete sequencing and characterization of 21,243 full-length
human cDNAs. Nat Genet. 36:40–45. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cheng D, Fan J, Ma Y, Zhou Y, Qin K, Shi M
and Yang J: LncRNA SNHG7 promotes pancreatic cancer proliferation
through ID4 by sponging miR-342-3p. Cell Biosci. 9:282019.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhong X, Long Z, Wu S, Xiao M and Hu W:
LncRNA-SNHG7 regulates proliferation, apoptosis and invasion of
bladder cancer cells assurance guidelines. J BUON. 23:776–781.
2018.PubMed/NCBI
|
|
24
|
Wang MW, Liu J, Liu Q, Xu QH, Li TF, Jin S
and Xia TS: LncRNA SNHG7 promotes the proliferation and inhibits
apoptosis of gastric cancer cells by repressing the P15 and P16
expression. Eur Rev Med Pharmacol Sci. 21:4613–4622.
2017.PubMed/NCBI
|
|
25
|
Luo X, Song Y, Tang L, Sun DH and Ji DG:
LncRNA SNHG7 promotes development of breast cancer by regulating
microRNA-186. Eur Rev Med Pharmacol Sci. 22:7788–7797.
2018.PubMed/NCBI
|
|
26
|
Villanueva MT: Anticancer drugs: All roads
lead to EZH2 inhibition. Nat Rev Drug Discov. 16:2392017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang XM, Shi SS, Jian TM, Tang DR, Wu T
and Sun FY: LncRNA PVT1 knockdown affects proliferation and
apoptosis of uveal melanoma cells by inhibiting EZH2. Eur Rev Med
Pharmacol Sci. 23:2880–2887. 2019.PubMed/NCBI
|
|
28
|
Li Z, Hou P, Fan D, Dong M, Ma M, Li H,
Yao R, Li Y, Wang G, Geng P, et al: The degradation of EZH2
mediated by lncRNA ANCR attenuated the invasion and metastasis of
breast cancer. Cell Death Differ. 24:59–71. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jia B, Xie T, Qiu X, Sun X, Chen J, Huang
Z, Zheng X, Wang Z and Zhao J: Long noncoding RNA FALEC inhibits
proliferation and metastasis of tongue squamous cell carcinoma by
epigenetically silencing ECM1 through EZH2. Aging (Albany NY).
11:4990–5007. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45((W1)):
W98–W102. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chandrashekar DS, Bashel B, Balasubramanya
SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK and
Varambally S: UALCAN: A portal for facilitating tumor subgroup gene
expression and survival analyses. Neoplasia. 19:649–658. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Schneider CA, Rasband WS and Eliceiri KW:
NIH image to ImageJ: 25 years of image analysis. Nat Methods.
9:671–675. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mas-Ponte D, Carlevaro-Fita J, Palumbo E,
Hermoso Pulido T, Guigo R and Johnson R: LncATLAS database for
subcellular localization of long noncoding RNAs. RNA. 23:1080–1087.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chaudhary R and Lal A: Long noncoding RNAs
in the p53 network. Wiley Interdiscip Rev RNA. 8:2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Van Raamsdonk CD, Griewank KG, Crosby MB,
Garrido MC, Vemula S, Wiesner T, Obenauf AC, Wackernagel W, Green
G, Bouvier N, et al: Mutations in GNA11 in uveal melanoma. N Engl J
Med. 363:2191–2199. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sun J, Pan LM, Chen LB and Wang Y: LncRNA
XIST promotes human lung adenocarcinoma cells to cisplatin
resistance via let-7i/BAG-1 axis. Cell Cycle. 16:2100–2107. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ding X, Wang X, Lin M, Xing Y, Ge S, Jia
R, Zhang H, Fan X and Li J: PAUPAR lncRNA suppresses tumourigenesis
by H3K4 demethylation in uveal melanoma. FEBS Lett. 590:1729–1738.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jiang X, Yang Z and Li Z: Zinc finger
antisense 1: A long noncoding RNA with complex roles in human
cancers. Gene. 688:26–33. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lan X, Sun W, Dong W, Wang Z, Zhang T, He
L and Zhang H: Downregulation of long noncoding RNA H19 contributes
to the proliferation and migration of papillary thyroid carcinoma.
Gene. 646:98–105. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liang WQ, Zeng, Chen CF, Sun SM, Lu XF,
Peng CY and Lin HY: Long noncoding RNA H19 is a critical oncogenic
driver and contributes to epithelial-mesenchymal transition in
papillary thyroid carcinoma. Cancer Manag Res. 11:2059–2072. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Shan Y, Ma J, Pan Y, Hu J, Liu B and Jia
L: LncRNA SNHG7 sponges miR-216b to promote proliferation and liver
metastasis of colorectal cancer through upregulating GALNT1. Cell
Death Dis. 9:7222018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Pandiani C, Beranger GE, Leclerc J,
Ballotti R and Bertolotto C: Focus on cutaneous and uveal melanoma
specificities. Genes Dev. 31:724–743. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kim KH and Roberts CW: Targeting EZH2 in
cancer. Nat Med. 22:128–134. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
McCabe MT, Ott HM, Ganji G, Korenchuk S,
Thompson C, Van Aller GS, Liu Y, Graves AP, Della Pietra A III,
Diaz E, et al: EZH2 inhibition as a therapeutic strategy for
lymphoma with EZH2-activating mutations. Nature. 492:108–112. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Varambally S, Dhanasekaran SM, Zhou M,
Barrette TR, Kumar-Sinha C, Sanda MG, Ghosh D, Pienta KJ, Sewalt
RG, Otte AP, et al: The polycomb group protein EZH2 is involved in
progression of prostate cancer. Nature. 419:624–629. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zingg D, Debbache J, Schaefer SM, Tuncer
E, Frommel SC, Cheng P, Arenas-Ramirez N, Haeusel J, Zhang Y,
Bonalli M, et al: The epigenetic modifier EZH2 controls melanoma
growth and metastasis through silencing of distinct tumour
suppressors. Nat Commun. 6:60512015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chen S, Pu J, Bai J, Yin Y, Wu K, Wang J,
Shuai X, Gao J, Tao K, Wang G and Li H: EZH2 promotes
hepatocellular carcinoma progression through modulating
miR-22/galectin-9 axis. J Exp Clin Cancer Res. 37:32018. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Hubaux R, Thu KL, Coe BP, MacAulay C, Lam
S and Lam WL: EZH2 promotes E2F-driven SCLC tumorigenesis through
modulation of apoptosis and cell-cycle regulation. J Thorac Oncol.
8:1102–1106. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Bachmann IM, Halvorsen OJ, Collett K,
Stefansson IM, Straume O, Haukaas SA, Salvesen HB, Otte AP and
Akslen LA: EZH2 expression is associated with high proliferation
rate and aggressive tumor subgroups in cutaneous melanoma and
cancers of the endometrium, prostate, and breast. J Clin Oncol.
24:268–273. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kivelä T and Kujala E: Prognostication in
eye cancer: The latest tumor, node, metastasis classification and
beyond. Eye (Lond). 27:243–252. 2013. View Article : Google Scholar : PubMed/NCBI
|
